ORLANDO, Fla. — Every-one knows someone who has been affected by the “C” word. We live in a country where ap-proximately one of every two men will develop cancer, and one of every three women. But 33,000 members of the Ameri-can Association for Cancer Research (AACR) are working diligently to change that.

Over 6,000 abstracts (re-search summaries) were pre-sented at the annual AACR meeting, held April 2-6, 2011, in Orlando, Florida. Research-ers presented abstracts on treatment possibilities and study results for the more than 200 types of cancer. Wake For-est Baptist researchers Dr. Ann Tallant and Dr. Patricia Gal-lagher offered one of the most innovative abstracts on the in-hibition of cancer cell growth not by a new pharmaceutical drug, but by muscadine grapes.

Dr. Tallant and Dr. Gallagher, professors in the Hypertension and Vascular Research Center at Wake Forest Health Sciences in Winston-Salem, conducted a discussion of their clinical study on “Inhibition of Cancer Cell Growth by Muscadine Grape Seed and Grape Skin Extracts” April 5, 2011, at the Orange County Convention Center. The product tested was a natural dietary supplement from Nature’s Pearl, headquartered in Advance.

-

-

-

-

-

-

-

-

-

-

-

Nature’s Pearl muscadines

Thursday, April 14, 2011

Muscadine grapes on the vine

in cancer research study

The abstract detailed the investigation of muscadine grape seed and skin extract’s effects on seven types of human can

cancer cells, Nature’s Pearl

the seven cancers in the Petri dishes.

muscadine extract inhibited or stopped the growth of each of

cers: lung, colon, breast, skin, brain and leukemia cancers in vitro. In every type of human

the highest inhibition of can

highest concentration of mus

cancer inhibited 80.5% (highest dose).

have also conducted subse

of Nature’s Pearl muscadine

from various funding nonprof

involved natural products instead of pharmaceutical drugs.

The researchers found that

cer growth tested was in the triple negative breast cancer cells: 92.6% inhibition at the

cadine extract. Other cancers

tion by the muscadine extract: human lung adenocarcinoma stopped by 81.8% (at highest concentration); human colon

Drs. Tallant and Gallagher

quent studies on the effects

extract on cancer cell growth, and they are seeking grants

its for further research. Their research stood out among the 6,000 abstracts announced at the 2011 AACR meeting, since a minority of abstracts

the disease. Even the researchers at the 2011 meeting com

progress made.

Listening to the myriad of

vention inspired hope for the future of all those affected by

mented on how their families had been devastated by cancer, and their intense desire to see

51st Year, Number 19 Clemmons, NC 27012 USPS 564-300